Nov. 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics ...

Pre-earnings options volume in Rani Therapeutics (RANI) Holdings is normal with calls leading puts 15:2. Implied volatility suggests the market is anticipating a move near 12.6%, or 30c, after results ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Oppenheimer has recently initiated Rani Therapeutics Holdings Inc (RANI) stock to Outperform rating, as announced on August 2, 2024, according to Finviz. Earlier, on June 14, 2024, Maxim Group had ...

“Karma, hard work and moving on" – this has been Rani Rampal's mantra throughout her remarkable journey. Now, having hung up her boots and stick, she's ready to wear the mentor's cap.

Oppenheimer has recently initiated Rani Therapeutics Holdings Inc (RANI) stock to Outperform rating, as announced on August 2, 2024, according to Finviz. Earlier, on June 14, 2024, Maxim Group had ...

In the Tokyo Olympics, Vandana Katariya was India's star turn. Leading the line for the national hockey team, she became the first Indian woman to score a hattrick in the Olympics, but when the ...

Former Indian women's hockey team captain Rani Rampal announced her retirement on Thursday, ending a glittering 16-year career during which she became an inspiration for beating abject poverty and ...

Rani Rampal, one of India's greatest ever sportspersons, played a pivotal role in improving the standards of the women's hockey team. Her career began at age 14 in 2009 and culminated in India's ...

Viking Therapeutics (NASDAQ:VKTX) added ~18% on Thursday to reach a five-month high as Wall Street focused on updates on its obesity candidate VK2735, even as the company posted better-than ...

The stock price of Rani Therapeutics Holdings Inc (NASDAQ: RANI) has dropped by -7.39 compared to previous close of 2.57. Despite this, the company has seen a gain of 12.26% in its stock price over ...

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) provided a look at new preclinical data for a glucagon-like peptide-1 (GLP-1) incretin triagonist. In addition to a discussion to this data ...